Modification of fentanyl analgesia by antidepressants

Pharmacology

Volumn 85, Issue 1, 2010, Pages 48-53

  Juś, Anna ^a   Bujalska, Magdalena ^a   Makulska Nowak, Helena E ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute and chronic pretreatment; Antidepressants; Fentanyl; Pain; Rats

Indexed keywords

AMITRIPTYLINE; FENTANYL CITRATE; FLUOXETINE; MOCLOBEMIDE; REBOXETINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG SYNERGISM; FENTANYL; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, INBRED WKY;

EID: 72149109033     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268105     Document Type: Article

References (43)

1. Ortega-Alvaro A, Acebes I, Saracobar G, Echevarria E, Casis L, Mico JA: Effect of the antidepressant nafazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain. Psychopharmacology 2004; 176: 305-311.
2. Mico JA, Ardid D, Berrocoso E, Eschalier A: Antidepressants and pain. Trends Pharmacol Sci 2006; 27: 348-354.
3. Nozaki C, Kamei J: Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice. Eur J Pharmacol 2006; 552: 99-104.
4. Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MG: A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998; 7: 291-300.
5. Butler SH, Weil-Fugazza J, Godefroy F, Besson JM: Reduction of arthritis and pain behavior following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. Pain 1985; 23: 159-175.
6. Matoba M: Use of morphine and adjuvant drugs according to the condition. Eur J Pain 2001; 5: 59-62.
7. Nicholson B: Reasonable prescribing of opioids for the management of chronic pain. Drugs 2003; 63: 17-32.
8. Nayebi ARM, Hassanpour M, Rezazadeh H: Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioral response in the formalin test in rats. J Pharm Pharmacol 2001; 53: 219-225.
9. Erjavec MK, Coda BA, Nguyen Q, Donaldson G, Risler L, Shen DD: Morphine-fluoxetine interactions in healthy volunteers: analgesia and side effects. J Clin Pharmacol 2000; 40: 1286-1295.
10. Kurumaji A, Mitsushio H, Takashima M: Chronic dietary treatment with antidepressants decrease brain Met-enkephalin-like immunoreactivity in the rat. Psychopharmacology 1988; 94: 188-192.
11. Kurlekar PN, Bhatt JD: Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice. Indian J Pharmacol 2004; 36: 369-372.
12. Gutierrez M, Ortega-Alvaro A, Gilbert-Rahola J, Mico JA: Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats. Neurosci Lett 2003; 352: 37-40.
13. Khoromi S, Cui L, Nackers L, Max BM: Morphine, nortriptyline and their combination vs placebo in patients with chronic lumbular root pain. Pain 2007; 130: 66-75.
14. Pakulska W, Czarnecka E: Influence of mianserin on the antinociceptive effect of morphine, metamizol and indomethacin in mice. Pharmacol Res 2002; 46: 415-423.
15. Singh VP, Jain NK, Kulkarni SK: On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 2001; 915: 218-226.
16. Gordon NC, Heller PH, Gear RW, Levine JD: Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain 1994; 58: 85-88.
17. Larson AA, Takemori AE: Effect of fluoxetine hydrochloride, a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sci 1977; 21: 1807-1812.
18. Yasuda T, Miki S, Yoshinaga N, Senba E: Effect of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axonomy. Pain 2005; 115: 161-170.
19. Lund A, Mjellem-Joly N, Hole K: Chronic administration of desipramine and zimelidine changes the behavioral response in the formalin test in rats. Neuropharmacology 1991; 30: 481-487.
20. Godefroy F, Butler SH, Weil-Fugazza J, Besson JM: Do acute or chronic tricyclic antidepressants modify morphine antinociception in arthritic rats? Pain 1986; 25: 233-244.
21. Pakulska W: Influence of sertraline on the antinociceptive effect of morphine, metamizol and indomethacin in mice. Acta Pol Pharm 2004; 61: 157-163.
22. Kellstein DE, Malseed RT, Ossipov MH, Goldstein FJ: Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines. Neuropharmacology 1988; 27: 1-14.
23. Kellstein DE, Malseed RT, Goldstein FJ: Contrasting effects of acute vs chronic tricyclic antidepressant treatment on central morphine analgesia. Pain 1984; 20: 323-334.
24. Raap DK, Evans S, Garcia F, Li Q, Muma NA, Wolf WA, Battaglia G, Van de Kar LD: Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT 1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther 1999; 288: 98-106.
25. Reisine T, Soubrie P: Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment. Eur J Pharmacol 1982; 77: 39-44.
26. Benkelfat C, Aulakh CS, Bykov V, Rice KC, De Costa BR, Rothman RB: Apparent downregulation of rat brain mu-and kappa-opioid binding sites labeled with [ 3 H]cycloFOXY following chronic administration of the potent 5-hdroxytryptamine reuptake blocker, clomipramine. J Pharm Pharmacol 1989; 41: 865-867
27. Goldstein FJ, Malseed RT, Nutz JF: Effect of chronic clomipramine on central DADLE antinociception. Pain 1990; 42: 331-336.
28. Vilpoux C, Carpentier C, Leroux-Niccolet I: Differential effects of chronic antidepressant treatments on μ-and σ-opiod receptors in rat brain. Eur J Pharmacol 2002; 443: 85-93.
29. Shirayama Y, Nishikawa T, Umino A, Takahashi K: p-Chlorophenylalanine- reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain. Eur J Pharmacol 1993; 237: 117-126.
30. Wahlstrom A, Lenhammar L, Ask B, Rane A: Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. Pharmacol Toxicol 1994; 75: 23-27.
31. 2-adrenoreceptors, μ-and κ-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment. Eur J Pharmacol 2006; 553: 269-279.
32. Reisine T, Soubrie P: Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment. Eur J Pharmacol 1982; 77: 39-44.
33. Stengaard-Pedersen K, Schou M: Opioid peptides and receptors in relation to affective illness: effect of desipramine and lithium on opioid receptors in rat brain. Acta Pharmacol Toxicol 1985; 56: 170-179.
34. Chen F, Lawrence AJ: Chronic antidepressant treatment causes a selective reduction of μ-opioid receptor binding and functional coupling to G proteins in the amygdala of fawn-hooded rats. J Pharmacol Exp Ther 2004; 310: 1020-1036.
35. De Felipe MC, De Ceballos ML, Gil C, Fuentes JA: Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat. Eur J Pharmacol 1985; 112: 119-122.
36. Acebes I, Echevarria E, Abecia LC, Barbero I, Maza JL, Casis L: Comparison of the effects of the administration of fluoxetine and sertraline on the immune markers of the mu opioid receptor in the rat brain. Rev Neurol 2000; 31: 919-922.
37. De Gandarias JM, Echevarria E, Acebes I, Abecia LC, Casis O, Casis L: Effects of fluoxetine administration on mu-opioid receptor immunostaining in the rat forebrain. Brain Res 1999; 817: 236-240.
38. Churruca I, Portillo MP: Fluoxetine alters mu opioid receptor expression in obese Zucker rat extrahypothalamic regions. Int J Neurosci 2006; 116: 289-298.
39. Przewłsocki R, Lasoń W, Turchan J, Przewłsocki B: Imipramine induces alterations in proenkephalin and prodynorphin mRNAs level in the nucleus accumbens and striatum in the rat. Pol J Pharmacol 1997; 49: 351-355.
40. O'Neill KA, Valentino D: Chronic desipramine attenuates morphine analgesia. Pharmacol Biochem Behav 1986; 24: 155-158.
41. Gould GG, Pardon MC, Morilak DA, Frazer A: Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems. Neuropsychopharmacology 2003; 28: 1633-1641.
42. Lesch KP, Hoh A, Schulte HM, Osterheider M, Muller T: Long-term fluoxetine treatment decreases 5-HT 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 1991; 105: 415-420.
43. Abbott FV, Young SN: Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test. Pharmacol Biochem Behav 1988; 31: 855-860.